CAS enhances chemotherapeutic drug-induced p53 accumulation and apoptosis: Use of CAS for high-sensitivity anticancer drug screening

Toxicology Mechanisms and Methods

Volumn 18, Issue 9, 2008, Pages 771-776

  Liao, Ching Fong ^a   Luo, Shue Fen ^b   Tsai, Chin Shaw Stella ^c,d   Tsao, Tang Yi ^c   Chen, Shun Liang ^c   Jiang, Ming Chung ^c  

^a INSTITUTE OF CELLULAR AND ORGANISMIC BIOLOGY   (Taiwan)

^b CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^c TUNGS' TAICHUNG METROHARBOR HOSPITAL   (Taiwan)

^d TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Anticancer drugs; Apoptosis; CAS; Green fluorescence protein; High throughput screening; p53

Indexed keywords

CELLULAR APOPTOSIS SUSCEPTIBILITY PROTEIN; CISPLATIN; DOXORUBICIN; FLUOROURACIL; GREEN FLUORESCENT PROTEIN; PROTEIN P53; TAMOXIFEN; TOXIN;

APOPTOSIS; ARTICLE; CANCER CELL; CELL DEATH; CONTROLLED STUDY; CYTOTOXICITY; DRUG SCREENING; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

EID: 57349097228     PISSN: 15376516     EISSN: 15376524     Source Type: Journal    
DOI: 10.1080/15376510802428609     Document Type: Article

References (19)

1. Behrens, P., Brinkmann, U., and Wellmann, A. 2003. CSE1L/CAS: its role in proliferation and apoptosis. Apoptosis 8:39-44.
2. Brinkmann, U., Brinkmann, E., Gallo, M., Scherf, U., and Pastan, I. 1996. Role of CAS, a human homologue to the yeast chromosome segregation gene CSE1, in toxin and tumor necrosis factor mediated apoptosis. Biochemistry 35:6891-6899.
3. Iwamoto, M., Yoshida, S., and Hirose, S. 1984. Fluorescence determination of 5-fluorouracil and 1-(tetrahydro-2-furanyl)-5-fluorouracil in blood serum by high-performance liquid chromatography. J. Chromatogr. 310:151-157.
4. Izaguirre, M.F., Vergara, M.N., and Casco, V.H. 2006. CAS role in the brain apoptosis of Bufo arenarum induced by cypermethrin. Biocell 30:309-320.
5. Jacob, S., Kaphalia, B.S., Jacob, N., and Ahmed, A.E. 2006. The water disinfectant byproduct dibromoacetonitrile induces apoptosis in rat intestinal epithelial cells: possible role of redox imbalance. Toxicol. Mech. Meth. 16:227-234.
6. Jiang, M.C., Luo, S.F., Li, L.T., Lin, C.C., Du, S.Y., Lin, C.Y., Hsu, Y.W., and Liao, C.F. 2007. Synergic CSE1L/CAS, TNFR-1, and p53 apoptotic pathways in combined interferon-gamma/adriamycin-induced apoptosis of Hep G2 hepatoma cells. J. Exp. Clin. Cancer Res. 26:91-99.
7. Liao, C.F., Luo, S.F., Li, L.T., Lin, C.Y., Chen, Y.C., and Jiang, M.C. 2008a. CSE1L/CAS, the cellular apoptosis susceptibility protein, enhances invasion and metastasis but not proliferation of cancer cells. J. Exp. Clin. Cancer Res. 27:15. doi: 10.1186/1756-9966-27-15.
8. Liao, C.F., Luo, S.F., Shen, T.Y., Lin, C.H., Chien, J.T., Du, S.Y., and Jiang, M.C. 2008b. CSE1L/CAS, a microtubule-associated protein, inhibits taxol (paclitaxel)-induced apoptosis but enhances cancer cell apoptosis induced by various chemotherapeutic drugs. BMB Rep. 41:210-216.
9. Lövborg, H., Gullbo, J., and Larsson, R. 2005. Screening for apoptosis-classical and emerging techniques. Anticancer Drugs 16:593-599.
10. Moriquand, J., Bartoli, M.H., Mermet, M.A., Stage, J.C., and Moriquand, C.L. 1985. Determination of hormoneresponsive breast tumor cells by tamoxifen induced fluorescence. Pathologica 77:273-279.
11. Pierce, R.N., and Jatlow, P.I. 1979. Measurement of adriamycin (doxorubicin) and its metabolites in human plasma using reversed-phase high-performance liquid chromatography and fluorescence detection. J. Chromatogr. 164:471-478.
12. Ramaiah, S.K., and Jaeschke, H. 2007. Hepatic neutrophil infiltration in the pathogenesis of alcohol-induced liver injury. Toxicol. Mech. Meth. 17:431-440.
13. Sharifi, A.M., and Mousavi, S.H. 2008. Studying the effects of lead on DNA fragmentation and proapoptotic Bax and antiapoptotic Bcl-2 protein expression in PC12 cells. Toxicol. Mech. Meth. 18:75-79.
14. Sharma, M., Jain, R., Ionescu, E., and Slocum, H.K. 1995. Capillary electrophoretic separation and laser-induced fluorescence detection of the major DNA adducts of cisplatin and carboplatin. Anal. Biochem. 228:307-311.
15. Shoemaker, R.H., Scudiero, D.A., Melillo, G., Currens, M.J., Monks, A.P., Rabow, A.A., Covell, D.G., and Sausville, E.A. 2002. Application of high-throughput, molecular-targeted screening to anticancer drug discovery. Curr. Top. Med. Chem. 2:229-246.
16. Singh, A.K., Yin Jiang, Y., and Gupta, S. 2007. Effects of bacterial toxins on endothelial tight junction in vitro: a mechanism-based investigation. Toxicol. Mech. Meth. 17:331-347.
17. Stankiewicz, A., and Skrzydlewska, E. 2006. Amifostine-antioxidant drug in anticancer therapy. Toxicol. Mech. Meth. 16:181-188.
18. 2α. Biomed. Pharmacother. (2008). doi: 10.1016/j.biopha.2008.07.09.
19. Wang, S., and El-Deiry, W.S. 2004. The p53 pathway: targets for the development of novel cancer therapeutics. Cancer Treat. Res. 119:175-187.